Advance Access & Delivery

Name

Advance Access & Delivery

Legal name

Advance Access & Delivery, Inc.

Website

https://www.advanceaccessanddelivery.org

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Global Public Health Services

NAICS

Health Care and Social Assistance (62), Outpatient Mental Health and Substance Abuse Centers (621420), Social Assistance (624)

SIC

Services-Health Services (8000)

akta.pro industry

PRIMARYHLAJAOAE

Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs)

Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health Initiatives & Partnerships

SECONDARYHLAKAGAH

Tuberculosis & Mycobacterial Diseases

Healthcare & Life Sciences/Specialist Medical Practice/Infectious Disease

SECONDARYBPAIAJAI

Non-Communicable Disease Prevention & Chronic Disease Programs

Business & Public Services/Public Sector & Government Administration/Public Health Administration & Regulation

SECONDARYBPADANAJ

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation

Business & Public Services/International Organizations & Development/International Standards, Policy & Regulatory Cooperation

Keywords

• Global health delivery
• Tuberculosis elimination
• Harm reduction services
• Infectious disease care
• Medicines access

Headquarters

HQ city

Durham

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Donations and Grants: AA&D is a 501(c)(3) nonprofit organization that operates primarily through donations and grant funding. The organization accepts monetary contributions through its website to support programs and operations.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

AA&D is a 501(c)(3) nonprofit that develops and operates programs expanding access to medicines and delivering infectious disease, harm reduction, and social support care for economically and socially marginalized groups worldwide. The organization coordinates the Zero TB Initiative global coalition, runs the TB Drug Access Atlas web platform, implements the 5-year NCD-LINK integrated TB and NCD care project in South Africa, manages the US-Mexico Border Initiative for binational TB control, and supports harm reduction services for drug users and homeless individuals.

Product overview

Advance Access & Delivery is a 501(c)(3) nonprofit organization that catalyzes new global health care delivery platforms. The organization operates several interconnected programs including the Zero TB Initiative (a comprehensive Search-Treat-Prevent framework), the TB Drug Access Atlas (a web-based platform for mapping MDR-TB drug supply), NCD-LINK (a 5-year project linking TB services with non-communicable disease care), the US-Mexico Border Initiative, and Harm Reduction programs. These offerings work together to overcome barriers to high quality health care and medicines for economically and socially marginalized groups globally.

Differentiator

Problem solved

Functional benefit

Brands

• Zero TB Initiative: A global coalition of non-profits, research institutions, public and private entities, and patient advocacy groups seeking to eliminate TB globally through a comprehensive Search-Treat-Prevent strategy.
• TB Drug Access Atlas
• NCD-LINK

Products and services

• Zero TB Initiative
• TB Drug Access Atlas
• NCD-LINK
• US-Mexico Border Initiative
• Harm Reduction Program

Quantifiable outcome

• Over 2,500 homeless individuals screened for COVID-19, TB, and HIV in Durban during South Africa lockdown
• +1 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

16 partnerships are on record, tiered core and supporting.

• Durban University of TechnologycoreStrategic or Co-development PartnerAA&D collaborated with Durban University of Technology to provide medical withdrawal program for homeless individuals in Durban during South Africa's lockdown. The partnership created a medical team including nurses and social workers to provide health and psychosocial services to people who use drugs.
• Lilly MDR-TB PartnershipcoreStrategic or Co-development PartnerIn March 2018, AA&D and the Lilly MDR-TB Partnership launched the TB Drug Access Atlas, a web-based platform mapping global TB drug supply efforts. The platform highlights over 40 global projects addressing challenges related to MDR-TB drug access.
• Interactive Research & Development-South Africa (IRD-SA)coreImplementation/ SI/ Consulting PartnerIRD-SA serves as implementation lead for the NCD-LINK project, a 5-year initiative linking TB services with NCD care in 10 public facilities across Umlazi, Durban.
• South African Medical Research CouncilcoreStrategic or Co-development PartnerThe South African Medical Research Council leads the monitoring and evaluation arm of the NCD-LINK project for integrated TB and NCD screening in South Africa.
• Partners In HealthcoreStrategic or Co-development PartnerPartners In Health is described as an affiliated organization. AA&D's Innovation Fund donation option directs 8% of donations to PIH, which supports groundbreaking TB elimination work in Lima and Russian Federation. PIH is a global leader in healthcare delivery.
• MASS Design GroupcoreStrategic or Co-development PartnerAA&D partnered with MASS Design Group to develop design criteria and recommendations for improving facilities and services for drug users and homeless individuals in Durban. The partnership aims to create an integrated center for low-income and homeless people with substance-use disorders.
• TB HIV CaresupportingStrategic or Co-development PartnerTB HIV Care provides critical support and harm reduction resources for Durban's drug user community. Partnered with AA&D on facility design and harm reduction services.
• Duke UniversitycoreStrategic or Co-development PartnerAA&D works with Duke University's Sanford School of Public Policy on multiple initiatives including START Coalition, TB-Diabetes report, and refugee community programs. Duke's Center for International Development features AA&D's work.
• University of North Carolina Chapel HillcoreStrategic or Co-development PartnerUNC Chapel Hill partners with AA&D on refugee wellness initiatives in North Carolina and on a project addressing mental health needs among internally displaced Yazidi mothers and children in Iraq. Includes collaboration with Gillings School of Global Public Health.
• University of GarmiancoreStrategic or Co-development PartnerUniversity of Garmian in Iraq collaborates with AA&D and UNC on research to understand mental health challenges and gaps in care for internally displaced Yazidi mothers and children. Dr. Pegah Seidi and Nazdar Qudrat Abas lead in-country implementation.
• Zero TB InitiativecoreStrategic or Co-development PartnerAA&D serves as the current secretariat for the Zero TB Initiative, a global coalition of nonprofits, research institutions, public and private entities, and patient advocacy groups working to eliminate TB through comprehensive Search-Treat-Prevent strategies.
• START CoalitioncoreStrategic or Co-development PartnerAA&D Executive Director Tom Nicholson serves on the steering committee of the START Coalition, an alliance of experts from academia, healthcare, business, and technology working on COVID-19 data and prevention strategies.
• Refugee Community PartnershipsupportingStrategic or Co-development PartnerRefugee Community Partnership is a community-driven organization based in Carrboro, NC focused on intentional support for relocated families. Collaborates with AA&D on refugee healthcare access initiatives.
• Center for New North CarolinianssupportingStrategic or Co-development PartnerCNNC is a UNC Greensboro center to promote access and integration for refugees and immigrants. Works with AA&D on understanding healthcare access challenges and developing training materials for community health workers.
• Harvard Medical SchoolcoreStrategic or Co-development PartnerHarvard Medical School collaborated with AA&D on the TB-Diabetes report. Dr. Salmaan Keshavjee is affiliated with Harvard and serves as AA&D Board Vice President.
• City of DurbancoreStrategic or Co-development PartnerThe City of Durban partnered with AA&D on the homeless screening initiative during COVID-19 lockdown, selecting reception centers and coordinating care across 10 decentralized sites for over 2,500 homeless individuals.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Partners In Health: Affiliated nonprofit delivering healthcare to the poor globally, including TB elimination work in Lima and Russia. AA&D's Innovation Fund routes a share of donations to PIH, and the organizations share leadership (Dr. Keshavjee). Most directly comparable on mission and operational model.
• Stop TB Partnership: UN-hosted global coalition coordinating TB elimination efforts, including the Global Drug Facility referenced in AA&D's coverage. Operates in overlapping TB advocacy and medicines access space with AA&D's Zero TB Initiative and TB Drug Access Atlas.
• Interactive Research and Development (IRD): Implementation partner on AA&D's NCD-LINK project and Zero TB Initiative in Bangladesh. Operates similar community-based TB screening and integrated care models in South Africa and South Asia with comparable donor and pharma backing.
• TB HIV Care: South Africa-based nonprofit providing TB and HIV services plus harm reduction programs. AA&D collaborates with TB HIV Care on Durban harm reduction facility design; comparable on TB service delivery and substance use harm reduction scope.
• Treatment Action Group (TAG): TB and HIV advocacy and policy organization. Comparable on TB policy advocacy, treatment access campaigns, and coalition-driven approach to advancing TB elimination agendas, though smaller and more focused on advocacy than direct delivery.

Broad incumbents

• Clinton Health Access Initiative (CHAI): Large-scale global health nonprofit working on HIV, TB, and NCD medicines access and pricing. Comparable on access-to-medicines mission and coalition-with-pharma approach, but operates at significantly larger scale across many more countries.
• Management Sciences for Health (MSH): Global health nonprofit focused on health systems strengthening and pharmaceutical management across low- and middle-income countries. Comparable on medicines access and integrated health system work, with broader geographic and technical scope than AA&D.
• Médecins Sans Frontières (MSF): International humanitarian medical organization providing TB and infectious disease care in conflict and crisis settings, including for displaced populations. Comparable on global TB treatment delivery and harm reduction work, but at vastly larger scale and emergency-response mandate.
• The Global Fund to Fight AIDS, Tuberculosis and Malaria: Multilateral financing institution funding TB, HIV, and malaria programs in low- and middle-income countries. Not a direct peer on operations, but the dominant funder shaping the TB funding environment in which AA&D's programs operate.

Emerging players

• Results for Development: Global health nonprofit working on health financing, NCD integration, and TB policy. Comparable on integrated NCD-TB care models and donor-engaged policy work, with overlapping funder base in global health foundations.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/media_aad

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Advance Access & Delivery